Northwestern Mutual Wealth Management Co. Has $12.47 Million Stock Position in CVS Health Corporation $CVS

Northwestern Mutual Wealth Management Co. lessened its holdings in shares of CVS Health Corporation (NYSE:CVSFree Report) by 7.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 120,524 shares of the pharmacy operator’s stock after selling 9,905 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in CVS Health were worth $12,468,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the company. Kilter Group LLC bought a new position in CVS Health in the second quarter valued at about $27,000. Beaird Harris Wealth Management LLC grew its position in CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the period. J.Safra Asset Management Corp purchased a new stake in CVS Health in the 2nd quarter valued at $30,000. Dunhill Financial LLC bought a new stake in CVS Health in the 2nd quarter worth about $32,000. Finally, Swiss RE Ltd. purchased a new stake in shares of CVS Health during the 4th quarter valued at $26,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have commented on CVS. Weiss Ratings raised shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Piper Sandler reissued an “overweight” rating on shares of CVS Health in a research note on Wednesday, August 26th. Barclays increased their target price on shares of CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. TD Cowen boosted their price objective on CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Finally, Bank of America boosted their price target on CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $107.17.

View Our Latest Stock Report on CVS

CVS Health Trading Down 0.4%

NYSE CVS opened at $97.20 on Thursday. The stock’s fifty day moving average price is $101.09 and its 200-day moving average price is $89.96. The stock has a market cap of $124.31 billion, a P/E ratio of 25.71, a P/E/G ratio of 0.95 and a beta of 0.59. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.7%. CVS Health’s dividend payout ratio is currently 70.37%.

About CVS Health

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.

Further Reading

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.